Movapo: Apomorphine belongs to the class of medications called anti-Parkinson's agents. It is used to treat the early return of stiffness and movement problems that occur when the effects …

Australian Register of Therapeutic Goods (ARTG) information for MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge.

2020年5月6日 · Movapo Pen, apomorphine hydrochloride hemihydrate 30 mg/3 mL is a disposable multiple dose pen injector system incorporating a clear glass (type I) cartridge …

MOVAPO PEN contains apomorphine which belongs to a group of medicines called dopaminergic compounds. Apomorphine is used in the treatment of Parkinson’s disease to reduce the …

MOVAPO PEN is a clear, colourless and practically particle free sterile solution for injection with a pH of 3.0 to 4.0. MOVAPO PEN is indicated to reduce the number and severity of ‘off’ phases …

MOVAPO PEN is indicated to reduce the number and severity of 'off' phases in patients with Parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. …

MOVAPO (Apomorphine hydrochloride 10mg/ml) is indicated for: The acute, intermittent treatment of hypomobility, “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) …

Movapo® is indicated for the acute, intermitent treatment of hypomobility, “OFF episodes (“end-of-dose wearing off and unpredictable “ON/OFF” episodes) in patients with advanced Parkinson’s …

MOVAPO PEN is used in the treatment of Parkinson’s disease to reduce the number and severity of bouts of freezing and stiffness (or “off” periods). For more information, see Section 1. Why …

Apomorphine is used in the treatment of Parkinson’s disease to reduce the number and severity of bouts of freezing and stiffness (or “off” periods). This medicine works by acting on dopamine …